Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Adenomatous Polyposis Coli 2Duodenal Neoplasms 1Attenuated familial adenomatous polyposis 1

Interventions

Specimen Handling 80Fluorouracil 76Oxaliplatin 70Magnetic Resonance Spectroscopy 61Leucovorin 60Gemcitabine 56Bevacizumab 56Biopsy 41Capecitabine 40Irinotecan 38Cisplatin 37pembrolizumab 35Nivolumab 35Cetuximab 33durvalumab 30130-nm albumin-bound paclitaxel 29Paclitaxel 27atezolizumab 21Folfox protocol 20Radiotherapy 17Carboplatin 17Taxes 16dehydroftorafur 15Cyclophosphamide 15Radiation 14fludarabine 13X-Rays 13Surgical Procedures, Operative 13Albumin-Bound Paclitaxel 13trastuzumab deruxtecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endoscopy, Gastrointestinal × Gastrointestinal × 30 days × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡